liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Pharmacogenomics in the Evaluation of Efficacy and Adverse Events During Clinical Development of Vaccines
Linköping University, Department of Clinical and Experimental Medicine, Pediatrics. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Center of Paediatrics and Gynaecology and Obstetrics, Department of Paediatrics in Linköping.
School of Pharmacy, University of Connecticut, Storrs, Connecticut, USA.
2008 (English)In: Pharmacogenomics in Drug Discovery and Development: From Bench to Bedside / [ed] Yan, Qing, New York, NY, United States: Humana Press, 2008, 1, 469-479 p.Chapter in book (Other academic)
Abstract [en]

The field of pharmacogenomics arose to develop personalized medicine, or medicine that deals with the complexity of the human body. In this book, leading experts present methodical, state-of-the-art contributions covering topics from individual molecules to systemic diseases, examining both fundamental concepts and advanced technologies. The volume begins by exploring cutting-edge technologies used to pursue systems-based pharmacogenomics, followed by extensive chapters on gene-drug interactions and the use of pharmacogenomics in therapeutics of diseases. This book is ideal for scientists striving to transform disease treatment into disease prevention.

Place, publisher, year, edition, pages
New York, NY, United States: Humana Press, 2008, 1. 469-479 p.
Series
Methods in Molecular Biology, ISSN 1064-3745 ; 448
Keyword [en]
Adverse reactions; clinical study; efficacy; microarray; PBMCs; pharmacogenomics; vaccine
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:liu:diva-44951DOI: 10.1007/978-1-59745-205-2_17Local ID: 78431ISBN: 978-1-58829-887-4 (print)ISBN: 978-1-59745-205-2 (print)OAI: oai:DiVA.org:liu-44951DiVA: diva2:265813
Available from: 2009-10-10 Created: 2009-10-10 Last updated: 2015-11-19Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textfind book at a swedish library/hitta boken i ett svenskt bibliotek

Authority records BETA

Nilsson, LennartRegnström, Karin J.

Search in DiVA

By author/editor
Nilsson, LennartRegnström, Karin J.
By organisation
PediatricsFaculty of Health SciencesDepartment of Paediatrics in Linköping
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar

doi
isbn
urn-nbn

Altmetric score

doi
isbn
urn-nbn
Total: 61 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf